BSEM (BioStem Technologies) Total Tax Payable: $0.0 Mil (As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSEM BioStem Technologies Inc BSEM
49 GF Score
Price $3.93
! 3 Warning Signs
View Full Analysis

What is BioStem Technologies Total Tax Payable?

BioStem Technologies BSEM -1.26% 49 Total Tax Payable is $0.0 Mil as of Sep. 2025. GuruFocus rates BSEM with a GF Score™ of 49/100. The stock has 3 warning signs investors should review.

BioStem Technologies's Total Tax Payable for the quarter that ended in Sep. 2025 was $0.0 Mil.

BioStem Technologies's quarterly Total Tax Payable declined from Sep. 2024 ($5.8 Mil) to Dec. 2024 ($2.9 Mil) and declined from Dec. 2024 ($2.9 Mil) to Sep. 2025 ($0.0 Mil).

BioStem Technologies's annual Total Tax Payable stayed the same from Dec. 2022 ($0.0 Mil) to Dec. 2023 ($0.0 Mil) but then increased from Dec. 2023 ($0.0 Mil) to Dec. 2024 ($2.9 Mil).

BioStem Technologies Total Tax Payable Related Terms

BioStem Technologies Total Tax Payable Historical Data

* Premium members only.

The historical data trend for BioStem Technologies's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioStem Technologies Total Tax Payable Chart

BioStem Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 2.91

BioStem Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Sep22 Dec22 Mar23 Sep23 Dec23 Sep24 Dec24 Sep25
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 5.83 2.91 0.00
BSEM
49GF Score
BioStem Technologies Inc BSEM
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioStem Technologies Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of $0.0 Mil mean?
BioStem Technologies (BSEM) has a Total Tax Payable of $0.0 Mil as of Sep. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on BioStem Technologies and its competitors.
Is BioStem Technologies' Total Tax Payable too high?
BioStem Technologies' current Total Tax Payable is $0.0 Mil. Overall, BioStem Technologies has a GF Score™ of 49/100, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Total Tax Payable compare to XLO and TCRX?
BioStem Technologies' Total Tax Payable of $0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Biotechnology company?
A good Total Tax Payable depends on the Biotechnology industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on BioStem Technologies and its competitors. BioStem Technologies's current Total Tax Payable is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
BioStem Technologies (BSEM) has a current Total Tax Payable of $0.0 Mil. The current Total Tax Payable is $0.0 Mil. BioStem Technologies' overall GF Score™ is 49/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Total Tax Payable is $0.0 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BioStem Technologies Business Description

Address 2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
49GF Score

Get the complete analysis for BSEM

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.93
Price